Tanvex BioPharma, Inc. (6541.TW) TAI
41.20
-0.65(-1.55%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.46B |
| Enterprise Value | 14.16B |
| P/E Ratio | -7.67 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 22.61 |
| Price/Book Ratio | 2.04 |
| Enterprise/Revenue | 25.16 |
| Enterprise/EBITDA | -12.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2.94 |
| Operating Margin | -2.89 |
Management Effectiveness
| Return On Assets | -0.19 |
| Return On Equity | -0.26 |
Income Statement
| Revenue | 400.97M |
| Revenue/Share | 1.83 |
| Gross Profit | -440.71M |
| EBITDA | -1.02B |
| Net Income | -1.5B |
| Diluted EPS | -6.13 |
Balance Sheet
| Total Cash | 442.24M |
| Total Cash/Share | 1.67 |
| Total Debt | 1.68B |
| Total Debt/Equity | 0.31 |
| Current Ratio | 1.33 |
| Book Value Per Share | 20.29 |
Price History
| 52-Week Change | -25.18 |
| 52-Week High | 68 |
| 52-Week Low | 37.3 |
| Moving Average 50 Days | 40.21 |
| Moving Average 200 Days | 49.82 |
Statistics
| Average Volume | 485,766 |
| Shares Outstanding | 264.99M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 333:1000 |
| Last Split Date | March 02, 2023 |
